Search

everythinglearnresearchcommunity

for

Search:↓

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Erlotinib can cause excessive eyelash growth.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

The 5/G hydrogel effectively improves diabetic wound healing.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

The gel with apigenin and celery juice promotes hair growth without causing skin irritation.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Upadacitinib improved multiple immune-related conditions in one patient.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

The gel with apigenin and celery juice improved hair growth in rats without causing skin irritation.

Ruxolitinib treatment may cause eyelash growth.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.